Statement on SVB
We extend our sympathy to all those who have been affected by the failure of Silicon Valley Bank. We have reviewed our portfolio companies to assess whether there is any…
0 Comments
14 March 2023
Mekonos Advisor awarded Nobel Prize in Chemistry
We join our portfolio company Mekonos in congratulating Professor Carolyn Bertozzi, who was awarded the Nobel Prize in Chemistry last week for her work in click chemistry with bioorthogonal reactions.…
10 October 2022
Mekonos announces partnership with Opentrons’ subsidiary Neochromosome
Our portfolio company #1 Mekonos has announced an exciting partnership to build designer chromosomes as part of the next generation of cell therapy. These therapies are the key to personalised…
15 December 2021
Portfolio Company #1 Mekonos raises oversubscribed USD$25 million round
We are proud to have participated in Mekonos' latest capital raise as we continue to support their ongoing development, stemming from research originally conducted at the University of Canterbury. Below…
10 November 2021
Mekonos named a Top San Francisco Life Science Start-up
Congratulations to the Mekonos team, who have been identified and recognised on a list of top Life Science start-ups based in San Francisco: https://beststartup.us/42-top-san-francisco-life-science-companies-and-startups-of-2021/
30 June 2021
Mekonos CEO highlighted in Founder Spotlight
Anil Narasimha, CEO of Mekonos, has given a great interview about how he got started with a career in Life Sciences, provided insights into Mekonos and its achievements, and talked…
16 June 2021
Mekonos featured on Startup Mindsets Podcast
Anil Narasimha, the CEO of our portfolio company Mekonos, has done an interview with Dan Gonzales and Earl Valencia on the Startup Mindsets podcast, discussing entrepreneurship in the biology space…
2 January 2021